Compound Eases Fibromyalgia Symptoms
July 1st 2009
New data suggests that sodium oxybate reduces pain associated with fibromyalgia.
Recently published data suggests that the compound sodium oxybate significantly reduces pain and other symptoms associated with fibromyalgia, according to several reports.
Jazz Pharmaceuticals Inc. announced the results sodium oxybate test trials last week during the 2009 Associated Professional Sleep Societies conference in Seattle, WA.
"The data showed that sodium oxybate improves the key symptoms of fibromyalgia: pain, fatigue, and sleep disturbances," said Dr. Todd Swick, one of the study's investigators, according to PR Newswire. "Millions of people are diagnosed with fibromyalgia and there is a continuing unmet need for therapies that address the constellation of symptoms that can have a significant impact on patients' quality of life."
Jazz Pharmaceuticals hopes to receive Food and Drug Administration approval for its fibromyalgia by the end of 2009. The Palo Alto, Calif.-based company already sells the sodium oxybate drug Xyrem in the U.S. market to treat narcolepsy. It’s European partner, Brussels-based HCB, markets Xyrem in Europe.